Westlake Chemical (WLK) Misses Q3 EPS, Revenues In-Line

Westlake Chemical (NYSE: WLK) reported Q3 EPS of $3.10, $1.42 worse than the analyst estimate of $4.52. Revenue for the quarter came in at $3.96 billion versus the consensus estimate of $3.99 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c